My watch list
my.bionity.com  
Login  

17 Current news of University of Texas at Galveston

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Drug to rejuvenate muscle cells developed

Elderly to feel fitter, faster and stronger

18-Feb-2019

Researchers from The University of Texas Medical Branch at Galveston have developed a promising drug that has proven to significantly increase muscle size, strength and metabolic state in aged mice, according to a study. As we age, our bodies increasingly lose the ability to repair and rebuild ...

more

image description
Why is junk food more attractive when on diet?

New insights into why we crave fatty foods when dieting

28-Jan-2019

Have you ever wondered why we crave the very foods that we try to avoid when dieting? Or wish there was a way to turn off the craving? Researchers from The University of Texas Medical Branch at Galveston have identified new brain circuits that may act as a brake on binge eating and junk food ...

more

UTMB adapts Zika vaccine to fight brain cancer

Vaccine attacked cancer cells but not healthy ones

19-Sep-2018

Researchers at The University of Texas Medical Branch at Galveston have successfully harnessed a Zika virus vaccine under development to target and kill the brain cancer known as glioblastoma. The findings are currently available in MBio. The Zika virus can cause microcephaly, a condition where ...

more

Why some people with brain markers of Alzheimer’s have no dementia

22-Aug-2018

A new study from The University of Texas Medical Branch at Galveston has uncovered why some people that have brain markers of Alzheimer’s never develop the classic dementia that others do. Alzheimer’s disease, the most common form of dementia, affects more than 5 million Americans. People ...

more

image description
Researchers develop Marburg virus treatment effective five days after infection

07-Apr-2017

An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical ...

more

New study uncovers mechanisms underlying how diabetes damages the heart

30-May-2016

Cardiac complications are the number one cause of death among diabetics. Now a team of scientists has uncovered a molecular mechanism involved in a common form of heart damage found in people with diabetes. A research team from The University of Texas Medical Branch at Galveston in collaboration ...

more

A new understanding of dengue virus

A new study is reshaping how scientists look at and understand a deadly virus

22-Sep-2015

An international consortium of scientists, including researchers from the University of Texas Medical Branch at Galveston, worked to map out the antigenic differences in various strains of dengue virus. Previously, scientists have described four distinct antigenic variants or serotypes. But ...

more

New drug protects against the deadly effects of nuclear radiation 24 hours after exposure

25-Aug-2015

An interdisciplinary research team led by The University of Texas Medical Branch at Galveston reports a new breakthrough in countering the deadly effects of radiation exposure. A single injection of a regenerative peptide was shown to significantly increase survival in mice when given 24 hours ...

more

image description
Chagas disease vaccine shows long-term protection in mice

12-May-2015

Chagas disease, caused by the Trypanosoma cruzi parasite and transmitted by insects in Latin America is among the most common tropical diseases, and so far without effective vaccine. A study published in PLOS Pathogens now shows that a candidate vaccine can induce long-lasting immunity against ...

more

Leading Ebola researcher at UTMB says there's an effective treatment for Ebola

04-Sep-2014

A leading U.S. Ebola researcher from the University of Texas Medical Branch at Galveston has gone on record stating that a blend of three monoclonal antibodies can completely protect monkeys against a lethal dose of Ebola virus up to 5 days after infection, at a time when the disease is ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE